There’s no word yet on when Metagenomi will enter the clinic. In its first quarterly update as a public company, the ...
Intellihealth signed on its largest client last year when it began providing weight-loss care and prescribing GLP-1s to ...
About a month after Oncopeptides lost its appeal with the FDA to continue the approval for Pepaxto in multiple myeloma ...
Moderna laid out its expectations for several vaccine markets Wednesday morning at an investor event as it continues moving ...
SK Life Science celebrated annual “Purple Day” for epilepsy awareness on Tuesday with a new mentoring program and a ...
India-based CDMOs have detected an uptick in biopharma client interest in their biologics and early-phase clinical offerings ...
$BOLD will take flight on Thurs­day morn­ing. Bound­less Bio, a San Diego can­cer biotech, will raise about $100 mil­lion in ...
Plus, news about a TUDCA study, PDS Biotechnology and Allarity Therapeutics: Gamida Cell to go private: The commercial-stage cell therapy biotech will no longer trade on the Nasdaq after Highbridge ...
Eversana and MyHealthTeam are pairing the former’s commercialization expertise with the latter’s dedicated patient social ...
Less than two months after betting $50 million on Beckley Psytech’s psychedelic drugs, atai Life Sciences has shared initial ...
Eli Lilly warned that two of its insulins will be in short supply through the beginning of April, though the Big Pharma ...
WuXi Biologics touted its partnerships and contracts in its annual report on Tuesday, noting that it has almost 700 projects ...